BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37737023)

  • 41. A novel method for administering intrathecal chemotherapy in patients with leptomeningeal metastases and shunted hydrocephalus: case report.
    Zada G; Chen TC
    Neurosurgery; 2010 Sep; 67(3 Suppl Operative):onsE306-7; discussion onsE307. PubMed ID: 20679917
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Cerebrospinal fluid examination after liposomal cytarabine intrathecal injection].
    Guillaume C; Vegas H; Pastuszka A; Le Brun C; Lanotte P
    Ann Biol Clin (Paris); 2018 Oct; 76(5):568-570. PubMed ID: 30154068
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical improvement and survival in breast cancer leptomeningeal metastasis correlate with the cytologic response to intrathecal chemotherapy.
    Clatot F; Philippin-Lauridant G; Ouvrier MJ; Nakry T; Laberge-Le-Couteulx S; Guillemet C; Veyret C; Blot E
    J Neurooncol; 2009 Dec; 95(3):421-426. PubMed ID: 19557501
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Proteomic Biomarker Identification in Cerebrospinal Fluid for Leptomeningeal Metastases with Neurological Complications.
    Galicia N; Díez P; Dégano RM; Guest PC; Ibarrola N; Fuentes M
    Adv Exp Med Biol; 2017; 974():85-96. PubMed ID: 28353226
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Complete remission in leptomeningeal metastasis of NSCLC with rare EGFR-SEPT14 fusion treated with osimertinib combined with intrathecal chemotherapy with pemetrexed.
    Zheng S; Li H; Feng J; Jiang C; Lin Y; Xie Y; Yu T; Qian X; Yin Z
    Anticancer Drugs; 2022 Jan; 33(1):e795-e798. PubMed ID: 34486539
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer.
    Malani R; Fleisher M; Kumthekar P; Lin X; Omuro A; Groves MD; Lin NU; Melisko M; Lassman AB; Jeyapalan S; Seidman A; Skakodub A; Boire A; DeAngelis LM; Rosenblum M; Raizer J; Pentsova E
    J Neurooncol; 2020 Jul; 148(3):599-606. PubMed ID: 32506369
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Current treatment of leptomeningeal metastases: systemic chemotherapy, intrathecal chemotherapy and symptom management.
    Berg SL; Chamberlain MC
    Cancer Treat Res; 2005; 125():121-46. PubMed ID: 16211887
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Leptomeningeal Metastases: New Opportunities in the Modern Era.
    Wilcox JA; Li MJ; Boire AA
    Neurotherapeutics; 2022 Oct; 19(6):1782-1798. PubMed ID: 35790709
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detection and outcome of occult leptomeningeal disease in diffuse large B-cell lymphoma and Burkitt lymphoma.
    Wilson WH; Bromberg JE; Stetler-Stevenson M; Steinberg SM; Martin-Martin L; Muñiz C; Sancho JM; Caballero MD; Davidis MA; Brooimans RA; Sanchez-Gonzalez B; Salar A; González-Barca E; Ribera JM; Shovlin M; Filie A; Dunleavy K; Mehrling T; Spina M; Orfao A
    Haematologica; 2014 Jul; 99(7):1228-35. PubMed ID: 24727817
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Leptomeningeal metastasis from solid tumors.
    Thakkar JP; Kumthekar P; Dixit KS; Stupp R; Lukas RV
    J Neurol Sci; 2020 Apr; 411():116706. PubMed ID: 32007755
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic validation and clinical implications of the EANO ESMO classification of leptomeningeal metastasis from solid tumors.
    Le Rhun E; Devos P; Weller J; Seystahl K; Mo F; Compter A; Berghoff AS; Jongen JLM; Wolpert F; Rudà R; Brandsma D; van den Bent M; Preusser M; Herrlinger U; Weller M
    Neuro Oncol; 2021 Jul; 23(7):1100-1112. PubMed ID: 33367859
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intrathecal liposomal cytarabine plus systemic therapy versus systemic chemotherapy alone for newly diagnosed leptomeningeal metastasis from breast cancer.
    Le Rhun E; Wallet J; Mailliez A; Le Deley MC; Rodrigues I; Boulanger T; Lorgis V; Barrière J; Robin YM; Weller M; Bonneterre J
    Neuro Oncol; 2020 Apr; 22(4):524-538. PubMed ID: 31637444
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Advances in Diagnosis and Treatment of Leptomeningeal Metastasis of Lung Cancer].
    Gao N; Xin T
    Zhongguo Fei Ai Za Zhi; 2022 Jul; 25(7):517-523. PubMed ID: 35899451
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A review of leptomeningeal metastases in pediatrics.
    Chamberlain MC
    J Child Neurol; 1995 May; 10(3):191-9. PubMed ID: 7642887
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The early recognition and diagnosis of neoplastic meningitis.
    Pellerino A; Bertero L; Pronello E; Rudà R; Soffietti R
    Expert Rev Neurother; 2024; 24(1):105-116. PubMed ID: 38145502
    [TBL] [Abstract][Full Text] [Related]  

  • 56. EpCAM-based flow cytometry in cerebrospinal fluid greatly improves diagnostic accuracy of leptomeningeal metastases from epithelial tumors.
    Milojkovic Kerklaan B; Pluim D; Bol M; Hofland I; Westerga J; van Tinteren H; Beijnen JH; Boogerd W; Schellens JH; Brandsma D
    Neuro Oncol; 2016 Jun; 18(6):855-62. PubMed ID: 26566655
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Carcinoma meningitis secondary to non-small cell lung cancer: combined modality therapy.
    Chamberlain MC; Kormanik P
    Arch Neurol; 1998 Apr; 55(4):506-12. PubMed ID: 9561978
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Meningeal carcinomatosis in patients with breast carcinoma. Clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen.
    Fizazi K; Asselain B; Vincent-Salomon A; Jouve M; Dieras V; Palangie T; Beuzeboc P; Dorval T; Pouillart P
    Cancer; 1996 Apr; 77(7):1315-23. PubMed ID: 8608509
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Investigation of Methods and Influencing Factors to Increase the Positive Rate of 
Cytological Pathology of Cerebrospinal Fluid from Lung Cancer Leptomeningeal Metastases].
    Gao N; Teng C; Fan C; Xin T
    Zhongguo Fei Ai Za Zhi; 2022 Nov; 25(11):789-796. PubMed ID: 36419392
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Whole brain radiotherapy combined with intrathecal liposomal cytarabine for leptomeningeal metastasis-a safety analysis and validation of the EANO-ESMO classification.
    Iglseder S; Nowosielski M; Bsteh G; Muigg A; Heugenhauser J; Mayer E; Grams A; Stockhammer G; Nevinny-Stickel M
    Strahlenther Onkol; 2022 May; 198(5):475-483. PubMed ID: 35267049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.